Literature DB >> 28839041

Complete Genome Sequence of Vitreoscilla filiformis (ATCC 15551), Used as a Cosmetic Ingredient.

Sandy Contreras1, Pierre Sagory-Zalkind2, Hélène Blanquart1, Agnès Iltis2, Stanislas Morand3.   

Abstract

We report the first complete genome sequence of a Vitreoscilla filiformis strain (ATCC 15551) that is used in the cosmetic industry as Vitreoscilla ferment. The assembled genome consisted of one chromosome and two plasmids. These data will provide valuable information and important insights into the physiology of this filamentous organism.
Copyright © 2017 Contreras et al.

Entities:  

Year:  2017        PMID: 28839041      PMCID: PMC5571427          DOI: 10.1128/genomeA.00913-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The nonpathogenic aerobic Gram-negative Vitreoscilla filiformis bacterium was named on the basis of its colorless gliding filamentous morphology (1). In the Pyrénées mountains, V. filiformis was spotted in spa muds used for skin cures and subsequently fermented at an industrial scale for more than 20 years to generate a bacterial lysate introduced into emollients. Studies have shown that this V. filiformis extract improved atopic dermatitis (2–5) by increasing keratinocyte antioxidant manganese superoxide dismutase (MnSOD) mitochondrial content (6) through a still-unknown mechanism. Currently, only two Vitreoscilla scaffold genomes are available (Vitreoscilla stercoraria and Vitreoscilla massiliensis). Here, we present the first complete genome sequence of a V. filiformis strain (ATCC 15551). Genomic DNA was isolated using the Gentra Puregene kit (Qiagen) following the manufacturer’s guidelines. Sequencing was performed by Genoscreen on a PacBio RS II system (Pacific Biosciences), following construction of a 10-kb SMRTbell library, and on a HiSeq 2500 system (Illumina), following construction of a 2-kb Nextera XT library. The generated long-read sequences (1,842,560,472 nucleotides; 116,681 reads) were de novo assembled using the single-molecule real-time (SMRT) analysis software version 2.3.0 followed by Circlator version 1.4.1 for circularization (7). The assembly quality was checked using 250-base paired-end short-read sequences (595,503,983 nucleotides; 1,250,485 reads) with BOWTIE2 version 2.1.0. The assembled genome comprised 3,765,551 bp, consisting of one chromosome (3,484,895 bp) and two plasmids, pVF1 (240,640 bp) and pVF2 (40,016 bp). Structural and functional annotations carried out by Genostar using a proprietary pipeline identified 6 rRNAs (5S, 16S, and 23S), 61 tRNAs, and 3,588 protein-coding sequences, of which 2,409 (67%) were annotated with known biological functions and 1,179 (33%) encode hypothetical proteins or uncharacterized proteins. The overall genome GC content (63.5%) fits that of a previous determination, ranging from 59 to 63% (1). The V. filiformis genome size (3.77 Mb) differs from those of the Vitreoscilla stercoraria (5.16 Mb, 43.9% GC) and Vitreoscilla massiliensis (7.43 Mb, 49.4% GC) genomes sequenced to date. The Vitreoscilla hemoglobin gene used in biotechnology processes is not present in the V. filiformis genome (8, 9). The V. filiformis bacterium is known to produce poly-β-hydroxybutyrate (PHB) granules that can accumulate to greater than half of its dry weight (1). Genome analysis confirmed the presence of the PHB operon (phbA, phbB, and phbC) as well as its regulator phaR. Interestingly, the PHAST algorithm (10) revealed that the chromosome comprises 5 similar prophage loci of ca. 38 kb with no resemblance to known phages. Moreover, a 10.5-kb region that contains transporter-, permease-, and transposase-encoding genes is duplicated twice on the chromosome and once on pVF2. Two large >7-kb-long clustered regularly interspaced short palindromic repeat (CRISPR) arrays composed of 117 and 129 repeats occur on the chromosome and pVF1, respectively. Strohl et al. (1) reported that, unlike V. stercoraria, V. filiformis uses glucose, citrate, lactate, aspartate, glutamate, succinate, or acetate as sole carbon and energy sources and nitrate (NO3−) as the sole nitrogen source and is resistant to neomycin. The mining of the complete genome sequence of V. filiformis will provide insights into the physiology of the Vitreoscilla genus, facilitating control of its industrial fermentation.

Accession number(s).

The complete genome sequence is available in GenBank under the accession numbers CP022423 to CP022425. The version described in this paper is the first version.
  9 in total

1.  Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms.

Authors:  A Guéniche; K Dahel; P Bastien; R Martin; J F Nicolas; L Breton
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-06       Impact factor: 6.166

Review 2.  Recent applications of Vitreoscilla hemoglobin technology in bioproduct synthesis and bioremediation.

Authors:  Benjamin C Stark; Krishna R Pagilla; Kanak L Dikshit
Journal:  Appl Microbiol Biotechnol       Date:  2015-01-11       Impact factor: 4.813

3.  Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract.

Authors:  Audrey Guéniche; Anca Hennino; Catherine Goujon; Karima Dahel; Philippe Bastien; Richard Martin; Roland Jourdain; Lionel Breton
Journal:  Eur J Dermatol       Date:  2006 Jul-Aug       Impact factor: 3.328

4.  The Vitreoscilla hemoglobin gene: molecular cloning, nucleotide sequence and genetic expression in Escherichia coli.

Authors:  C Khosla; J E Bailey
Journal:  Mol Gen Genet       Date:  1988-09

5.  Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.

Authors:  A Gueniche; B Knaudt; E Schuck; T Volz; P Bastien; R Martin; M Röcken; L Breton; T Biedermann
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

6.  Induction of the skin endogenous protective mitochondrial MnSOD by Vitreoscilla filiformis extract.

Authors:  Y F Mahé; R Martin; L Aubert; N Billoni; C Collin; F Pruche; P Bastien; S S Drost; A T Lane; A Meybeck
Journal:  Int J Cosmet Sci       Date:  2006-08       Impact factor: 2.970

7.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

8.  Circlator: automated circularization of genome assemblies using long sequencing reads.

Authors:  Martin Hunt; Nishadi De Silva; Thomas D Otto; Julian Parkhill; Jacqueline A Keane; Simon R Harris
Journal:  Genome Biol       Date:  2015-12-29       Impact factor: 13.583

9.  Clinical efficacy of emollients in atopic dermatitis patients - relationship with the skin microbiota modification.

Authors:  Sophie Seité; Hana Zelenkova; Richard Martin
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-01-12
  9 in total
  2 in total

Review 1.  Mud therapy and skin microbiome: a review.

Authors:  Michele Antonelli; Davide Donelli
Journal:  Int J Biometeorol       Date:  2018-08-08       Impact factor: 3.787

Review 2.  Vitreoscilla filiformis Extract for Topical Skin Care: A Review.

Authors:  Audrey Gueniche; Muriel Liboutet; Stephanie Cheilian; Dominique Fagot; Franck Juchaux; Lionel Breton
Journal:  Front Cell Infect Microbiol       Date:  2021-12-16       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.